Pain Reduction With Topical Bromfenac Versus Artificial Tear After Intravitreal Injection.

NCT06130384 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Pain
Intravitreal Injection
Pain, Acute

Interventions

DRUG: Use of bromfenac 0.09% to reduce intravitreal injection pain
DRUG: Use of artificial tears to reduce intravitreal injection pain

Sponsor

Wills Eye